PUNJABCHEMPunjab Chemicals & Crop Protection Limited
Chemicals · Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Punjab Chemicals and Crop Protection Limited manufactures and sells agrochemicals, specialty chemicals, bulk drugs, and related intermediates in India, Europe, Japan, Israel, the United States, Latin America, and internationally. It offers herbicides, including metamitron, ethofumesate, diflufenican, lenacil, and cyanazine; insecticides and fungicides; pharma active pharmaceutical ingredients (API) comprising trimethoprim IP/BP/USP/EP, etoricoxib, celecoxib, albendazole USP/BP/IP, drotaverine HCL; and pharma intermediates, advance intermediates for API, and antioxidants. The company provides fine and specialty chemicals; basic and industrial chemicals, such as oxalates and intermediates; and phosphorus derivatives and phosphates. In addition, it is involved in international trading of chemicals; and provision of research and development and contract manufacturing services. The company was incorporated in 1975 and is based in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on PUNJABCHEM — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • ROCE: 16.2%
- • Debt/Equity: 0.36
- • Promoter holding: 80.9%
- • Golden cross setup: SMA50 above SMA200
- • Supertrend: bullish
- • Trend strength (ADX): 27
Bull case
- • ROCE: 16.2%
- • Debt/Equity: 0.36
- • Promoter holding: 80.9%
- • Golden cross setup: SMA50 above SMA200
Bear case
- • Revenue growth: 8.7% YoY
- • Profit growth: 7.0% YoY
- • RSI: 37
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Momentum is fading versus the broader market
- • Revenue growth: 8.7% YoY
- • Profit growth: 7.0% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹35.50). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.